Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation

January 27, 2021 updated by: Cereneo AG
High motivation is a predictor for good therapy results in physical therapy [Grahn 2000]. The investigator want to show that it is possible to increase patients motivation for stroke rehabilitation by providing them objective performance feedback about the patients therapy progress.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

High motivation is a predictor for good therapy results in physical therapy [Grahn 2000]. Additional focus on motivation and rewards has fallen on the topic of stroke rehabilitation since it was shown in an animal model that the brain centers involved with motivation and rewards are crucial to motor learning [Hosp 2011].

The investigators goal is to target the overall motivation for therapy. During the guided therapy sessions the therapists will be the main motivators and the investigators do not want to interfere with that. But the amount of guided therapy sessions is often limited due to economical reason rather than therapeutic ones. Therefore patients are encouraged to do training on their own if possible and to be active during the patients stay in the rehabilitation clinic. The investigators target the patients motivation to train by themselves and be active but also the patients attitude towards the guided therapies. It is known that performance feedback can improve motivation [Harackiewicz 1979]. Therefore the investigators want to use the data about therapy progress to produce feedback for patients visualizing the patients progress and efforts during the patients stay in the clinic.

The investigators will compare patients who receive normal therapy to patients who receive normal therapy plus performance feedback regarding a variety of motivation measures.

Study Type

Interventional

Enrollment (Anticipated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lucerne
      • Vitznau, Lucerne, Switzerland, 6354
        • Cereneo, Center For Rehabilitation and Neurology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • First time Inpatient at the Cereneo rehabilitation clinic

Exclusion Criteria:

  • Rey-Figur Kopie <= 25 AND Rechnerisches Denken WIE <=5
  • Becks Depression Inventar (BDI) > 17
  • Major aphasia preventing understanding of study materials (according to the treating physician).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No intervention group
Patients in stroke rehabilitation receiving standard therapy
Active Comparator: Intervention group
Patients in stroke rehabilitation receiving standard therapy plus performance feedback
Performance Feedback regarding the patients efforts and accomplishments during the patients stay in the rehabilitation clinic, an expected average of 6 weeks. The data available about the patients progress will be analysed and processed to create a visual illustration shown to the patient on a daily bases.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motivation
Time Frame: Weekly for the duration of the participants stay at the hospital an expected average of 6 weeks
Weekly: Intrinsic Motivation Inventory Questionnaire
Weekly for the duration of the participants stay at the hospital an expected average of 6 weeks
Motivation
Time Frame: After each therapy session for the duration of the participants stay at the hospital an expected average of 6 weeks
Motivation rating of patients regarding the foregoing therapy session by therapists
After each therapy session for the duration of the participants stay at the hospital an expected average of 6 weeks
Motivation
Time Frame: Continuous for the duration of the participants stay at the hospital an expected average of 6 weeks
Time patient spends on self administered training
Continuous for the duration of the participants stay at the hospital an expected average of 6 weeks
Motivation
Time Frame: Continuousfor the duration of the participants stay at the hospital an expected average of 6 weeks
Amount of activities (walking, stair climbing) during free time
Continuousfor the duration of the participants stay at the hospital an expected average of 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical scores (e.g. Fugl-Meyer Score)
Time Frame: When decided by therapists for the duration of the participants stay at the hospital an expected average of 6 weeks
Standard quality assessments of the study site (rehabilitation clinic)
When decided by therapists for the duration of the participants stay at the hospital an expected average of 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

December 8, 2014

First Submitted That Met QC Criteria

December 10, 2014

First Posted (Estimate)

December 12, 2014

Study Record Updates

Last Update Posted (Actual)

February 1, 2021

Last Update Submitted That Met QC Criteria

January 27, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Performance Feedback

3
Subscribe